Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    FSA_thumbnail
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    Watch the webinar.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

ICON Plc facebook post
ICON Plc logo
ICON Plc

ICON will participate in the upcoming Medical Technology Enterprise Consortium (MTEC) webinar on 15 October from 1:00 pm to 2:00 pm. Tim Bradshaw and Edward Wright will speak on the topic: "Advancing ICON early-stage c...

13 Oct
1
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Connect with the ICON team during ACR Convergence 2025 at booth \#1501, to discover how Accellacare—our Global Site Network with deep expertise in osteoarthritis, osteoporosis, and rheumatoid arthritis—supports sponsors ...

13 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Biosimilars are gaining ground in APAC — but adoption depends on education. ICON’s latest blog dives into the real-world barriers to biosimilar uptake across Asia-Pacific, from low patient awareness to prescriber miscon...

13 Oct
1
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Biosimilars are positively impacting healthcare in APAC — but awareness and trust remain critical hurdles. ICON explores how strategic education and engagement can unlock biosimilar adoption across Asia-Pacific, from em...

13 Oct
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

More than 100 million people in the US have some form of liver disease. On November 7-11, meet the ICON team at AASLD, booth \#1041 to learn how we apply flexible partnership and delivery models, supported by robust to...

13 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

From a small-town GP to Site Head at ICON Bulgaria, Dimitar Karzhin’s story is one of purpose, growth, and community. Since joining ICON in 2011, Dimitar has seen our Bulgaria operations expand from a remote team of jus...

13 Oct
28
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

From a small-town GP to Site Head at ICON Bulgaria, Dimitar Karzhin, MD's story is one of purpose, growth, and community. Since joining ICON in 2011, Dimitar has seen our Bulgaria operations expand from a remote team of...

13 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

R, an open-source programming language for statistical computing, is transforming the role of clinical programmers. It enables reproducible research, supports cross team collaboration, and strengthens regulatory complian...

13 Oct
2
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

R, an open-source programming language for statistical computing, is transforming the role of clinical programmers. It enables reproducible research, supports cross team collaboration, and strengthens regulatory complian...

13 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

10 Oct
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

10 Oct
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Pediatric clinical trials have different processes, risks and challenges than adult trials. Identifying those differences is critical but can be difficult, especially if resources are limited. Join ICON’s Heather Peterso...

10 Oct
4
View post
View webpage
  • Previous
  • 1
  • …
  • 73
  • 74
  • 75
  • …
  • 95
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence